SEARCH
Expert panel recommends Bharat BioTech's Covaxin for restricted emergency use
India Today
2021-01-02
Views
170
Description
Share / Embed
Download This Video
Report
Covaxin, Bharat BioTech's Covid-19 vaccine, has become the second vaccine to be recommended for restricted emergency use from a government-appointed expert panel in India.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x7yft79" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
01:36
Bharat Biotech's Covaxin Recommended By Expert Panel For Phase II III Trials On 2-18 Year-Olds
01:23
WHO expert panel to decide today on emergency use nod to Bharat Biotech’s Covaxin | Oneindia News
01:25
Covaxin Emergency Use:India approves Serum-Oxford, Bharat Biotech's COVID vaccines for Emergency Use
01:49
Bharat Biotech’s Covid-19 vaccine Covaxin gets WHO’s emergency use approval | Oneindia News
01:49
Covaxin Phase 3 Trial Data: DCGI’s Expert Panel Says Bharat Biotech’s Vaccine 77.8% Effective
04:11
No emergency use approval for Bharat Biotech's Covaxin in US, FDA seeks more info & data
01:51
Bharat Biotech's Covaxin gets SEC approval for emergency use_ Sources
02:07
US drug regulator rejects emergency use approval for Bharat Biotech’s Covaxin
04:11
Watch | USFDA rejects Bharat Biotech's Covaxin for emergency use, Is rejection a setback for company?
01:32
Bharat Biotech's Covaxin Approved for Emergency Vaccination for 8-12 Age Group
07:47
Bharat Biotech's Covaxin granted emergency use approval for kids aged 2-18 years
04:09
India Approves Two COVID-19 Vaccines: Oxford-Serum Institute's Covishield & Bharat Biotech's Covaxin Receives Emergency Approval From DCGI
